Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.
- DOI
- 10.1002/ajh.70489
- Published
- 2026 Aug 31
- Container
- American journal of hematology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ajh.70489,
title = {Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.},
author = {Shaffer BC and Al Malki MM and Jimenez AMJ and Stanek J and Bo-Subait S and Logan BR and Kou J and Leckrone E and Stefanski HE and Spellman SR and Malmberg C and Askar M and Cusatis R and Modi D and Khimani F and Hamadani M and Maiers M and Cook R and Ballen K and Bolaños-Meade J and Rao U and Milner J and Abboud R and Jamieson K and Carrum G and Dholaria B and Hogan WJ and Reshef R and Kosuri S and Loren A and Larkin K and Arai S and Qayed M and Choi SW and Broglie L and Auletta JJ and Shaw BE and Devine SM and Gooptu M},
year = {2026},
journal = {American journal of hematology},
doi = {10.1002/ajh.70489},
url = {https://doi.org/10.1002/ajh.70489}
}RIS
TY - JOUR TI - Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort. AU - Shaffer BC AU - Al Malki MM AU - Jimenez AMJ AU - Stanek J AU - Bo-Subait S AU - Logan BR AU - Kou J AU - Leckrone E AU - Stefanski HE AU - Spellman SR AU - Malmberg C AU - Askar M AU - Cusatis R AU - Modi D AU - Khimani F AU - Hamadani M AU - Maiers M AU - Cook R AU - Ballen K AU - Bolaños-Meade J AU - Rao U AU - Milner J AU - Abboud R AU - Jamieson K AU - Carrum G AU - Dholaria B AU - Hogan WJ AU - Reshef R AU - Kosuri S AU - Loren A AU - Larkin K AU - Arai S AU - Qayed M AU - Choi SW AU - Broglie L AU - Auletta JJ AU - Shaw BE AU - Devine SM AU - Gooptu M PY - 2026 JO - American journal of hematology DO - 10.1002/ajh.70489 UR - https://doi.org/10.1002/ajh.70489 ER -
APA
BC, S., MM, A. M., AMJ, J., J, S., S, B., BR, L., J, K., E, L., HE, S., SR, S., C, M., M, A., R, C., D, M., F, K., M, H., M, M., R, C., K, B., J, B., U, R., J, M., R, A., K, J., G, C., B, D., WJ, H., R, R., S, K., A, L., K, L., S, A., M, Q., SW, C., L, B., JJ, A., BE, S., SM, D., & M, G. (2026). Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.. American journal of hematology. https://doi.org/10.1002/ajh.70489
Source records
- pubmed · retrieved 2026-09-25T10:33:27.142Z
- europe-pmc · retrieved 2026-09-25T10:33:27.174Z